211 related articles for article (PubMed ID: 24035532)
1. Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis.
Liao WC; Chien KL; Lin YL; Wu MS; Lin JT; Wang HP; Tu YK
Lancet Oncol; 2013 Oct; 14(11):1095-1103. PubMed ID: 24035532
[TBL] [Abstract][Full Text] [Related]
2. Systematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancer.
Zhu GQ; Shi KQ; You J; Zou H; Lin YQ; Wang LR; Braddock M; Chen YP; Zheng MH
Aliment Pharmacol Ther; 2014 Oct; 40(7):759-70. PubMed ID: 25099956
[TBL] [Abstract][Full Text] [Related]
3. Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.
Hu Q; Wang D; Chen Y; Li X; Cao P; Cao D
Radiat Oncol; 2019 Jul; 14(1):120. PubMed ID: 31291998
[TBL] [Abstract][Full Text] [Related]
4. Optimal adjuvant chemotherapy for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis.
Xu JB; Jiang B; Chen Y; Qi FZ; Zhang JH; Yuan H
Oncotarget; 2017 Oct; 8(46):81419-81429. PubMed ID: 29113401
[TBL] [Abstract][Full Text] [Related]
5. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma.
Hattangadi JA; Hong TS; Yeap BY; Mamon HJ
Cancer; 2009 Aug; 115(16):3640-50. PubMed ID: 19514088
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer.
Huang TC; Hsu CH; Lin CC; Tu YK
Jpn J Clin Oncol; 2015 Nov; 45(11):1023-8. PubMed ID: 26246479
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes in patients with early stage, resected pancreatic cancer - a comparison of gemcitabine- and 5-fluorouracil-based chemotherapy and chemoradiation regimens.
Kizilbash SH; Ward KC; Liang JJ; Jaiyesimi I; Lipscomb J
Int J Clin Pract; 2014 May; 68(5):578-89. PubMed ID: 24472057
[TBL] [Abstract][Full Text] [Related]
8. A systematic review and network meta-analysis of phase III randomised controlled trials for adjuvant therapy following resection of pancreatic ductal adenocarcinoma (PDAC).
Kamarajah SK; Bundred JR; Alrawashdeh W; Manas D; White SA
HPB (Oxford); 2020 May; 22(5):649-659. PubMed ID: 31894014
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based guidelines for adjuvant therapy for resected adenocarcinoma of the pancreas.
Iott MJ; Corsini MM; Miller RC
Clin J Oncol Nurs; 2008 Aug; 12(4):599-605. PubMed ID: 18676327
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy, with or without postoperative radiotherapy, for resectable advanced pancreatic adenocarcinoma: continue or stop?
Ren F; Xu YC; Wang HX; Tang L; Ma Y
Pancreatology; 2012; 12(2):162-9. PubMed ID: 22487527
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiation therapy versus chemotherapy alone for gastric cancer after R0 surgical resection: a meta-analysis of randomized trials.
Min C; Bangalore S; Jhawar S; Guo Y; Nicholson J; Formenti SC; Leichman LP; Du KL
Oncology; 2014; 86(2):79-85. PubMed ID: 24435019
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
13. Resection status, age and nodal involvement determine survival among patients receiving adjuvant chemoradiotherapy in pancreatic adenocarcinoma.
Moghanaki D; Mick R; Furth EE; Sohal D; Salmon PM; Behbahani A; Morgans AK; Miller SM; Giantonio BJ; Whittington RW; Haller DG; Rosato EF; Plastaras JP
JOP; 2011 Sep; 12(5):438-44. PubMed ID: 21904068
[TBL] [Abstract][Full Text] [Related]
14. Current state of adjuvant therapy in resected pancreatic adenocarcinoma.
Bergenfeldt M; Albertsson M
Acta Oncol; 2006; 45(2):124-35. PubMed ID: 16546857
[TBL] [Abstract][Full Text] [Related]
15. Economic Analysis of Adjuvant Chemoradiotherapy Compared with Chemotherapy in Resected Pancreas Cancer.
Vela N; Davis LE; Cheng SY; Hammad A; Liu Y; Kagedan DJ; Paszat L; Bubis LD; Earle CC; Myrehaug S; Mahar AL; Mittmann N; Coburn NG;
Ann Surg Oncol; 2019 Dec; 26(13):4193-4203. PubMed ID: 31535303
[TBL] [Abstract][Full Text] [Related]
16. Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma.
Schmidt J; Abel U; Debus J; Harig S; Hoffmann K; Herrmann T; Bartsch D; Klein J; Mansmann U; Jäger D; Capussotti L; Kunz R; Büchler MW
J Clin Oncol; 2012 Nov; 30(33):4077-83. PubMed ID: 23008325
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy for pancreatic cancer.
Sultana A; Cox T; Ghaneh P; Neoptolemos JP
Recent Results Cancer Res; 2012; 196():65-88. PubMed ID: 23129367
[TBL] [Abstract][Full Text] [Related]
18. Advancements in the management of pancreatic cancer: 2013.
Saif MW
JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
Stocken DD; Büchler MW; Dervenis C; Bassi C; Jeekel H; Klinkenbijl JH; Bakkevold KE; Takada T; Amano H; Neoptolemos JP;
Br J Cancer; 2005 Apr; 92(8):1372-81. PubMed ID: 15812554
[TBL] [Abstract][Full Text] [Related]
20. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
Garcia-Aguilar J; Chow OS; Smith DD; Marcet JE; Cataldo PA; Varma MG; Kumar AS; Oommen S; Coutsoftides T; Hunt SR; Stamos MJ; Ternent CA; Herzig DO; Fichera A; Polite BN; Dietz DW; Patil S; Avila K;
Lancet Oncol; 2015 Aug; 16(8):957-66. PubMed ID: 26187751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
